Drugs regulator recommends eptinezumab for adults whe three previous treatments have failed
Thousands of people in England and Wales who suffer from migraines could benefit from a drug that has been approved on the NHS.
The National Institute for Health and Care Excellence (Nice), the drugs regulator, said it was recommending eptinezumab for preventing migraine in about 164,000 adults where at least three previous preventive treatments had failed.
